Prognostic and therapeutic value of day 14 bone marrow aspiration in adult Acute Myeloid Leukemia patients
ConclusionBMA d14 has a significant prognostic impact on therapeutic outcome of AML patients (CR, DFS, and OS); however second induction of patients with BMd14 blast>5% should be delayed till neutrophil recovery to minimize death in aplasia.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Bone Marrow Aspiration and Biopsy | Cancer & Oncology | Chemotherapy | Genetics | Leukemia | Lymphoma | Myeloma | Study